ArticleScientific reports2026
Post-acute sequelae of SARS-CoV-2 infection symptom network centrality analysis of Taiwan population to unveil intricate symptomatology patterns.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID, present a complex array of persistent symptoms that remain poorly understood. Identifying the central symptoms and their interrelationships is crucial for effective management and intervention. This study applied network centrality analysis to 672 individuals diagnosed with COVID-19 in southern Taiwan, who completed an online survey on persistent symptoms. Participants were classified into two groups: post-acute COVID (symptoms lasting 4–12 weeks post-infection) and long COVID (symptoms lasting > 12 weeks). Symptom networks were constructed using polychoric correlations, with centrality measures (betweenness, closeness, strength, expected influence) used to assess symptom influence. A network comparison test evaluated invariance and global strength between the two groups. The mean age of participants was 38.75 years, with significant age differences between the post-acute COVID group (40.31 years) and the long COVID group (37.76 years). Diarrhea showed high betweenness centrality in both groups, acting as a key connector. Palpitations exhibited higher closeness centrality in long COVID, while fever was central in post-acute cases. Strength centrality was notably high for palpitations and chest pain in long COVID. No gender differences were found, and the global strength of the networks did not differ significantly between the groups (p = 0.93). This study reveals that long COVID has a more tightly interconnected symptom network compared to post-acute COVID, with central symptoms like palpitations and chest pain offering potential targets for tailored treatment strategies. The findings emphasize the importance of symptom interrelationships, though longitudinal studies are needed to further explore causal relationships and the progression of symptoms over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.